The North America Dry Eye Treatment Devices Market would witness market growth of 6.7% CAGR during the forecast period (2022-2028).
Meniscometry, optical coherence tomography, tear osmolarity, the tear film normalization test, interferometry, tear film stability analysis, ocular surface thermography, and tear biomarkers are examples of emerging technology. Relevant autoimmune disease history, corrective eye surgery or drug use, allergies or rosacea, and oral medicine use are all patient-specific factors to consider. Clinical examination for lid margin disease, the appearance of lagophthalmos, or aberrant blink patterns is further patient consideration.
In its ophthalmic medication products, the US Food and Drug Administration (FDA) has designated OTC artificial tears. Specific types of demulcents or emollients utilized for human use are based on their chemical components rather than therapeutic efficacy. An emollient is a fat or oil substance that is applied locally to eyelids to protect or soften tissues to prevent drying and cracking, and a demulcent is a water-soluble polymer agent that is topically applied to the eye to safeguard and lubricate mucous membrane surfaces and relieve dryness and irritation.
Artificial tears are also necessary for treating the signs and symptoms of dry eyes and are sold commercially without a prescription. The main drivers driving the dry eye treatment devices market include the rising incidence of dry eye syndrome, rising use of preservative-free artificial tears, growing preference for sophisticated solutions for post-surgery treatment for dry eyes, and technical advancements. In addition, the new artificial tear medications are in various phase studies for the US FDA clearance procedure.
The most common kind of eye disease in the US is dry eye syndrome. This is explained by the enormous patient population in this region. Women from the southern United States had a high frequency of dry eye syndrome. The quality of life and performance of dry eye patients may be negatively impacted by these indoor and outdoor elements. Patients with mild dry eye illness may also have a conjunctival injection, irritability, itching, pain, burning, or sporadic vision blurring. When ocular surface desiccation or keratinization is severe, visual impairment may also be brought on by scarring, thinning, or ulceration of the cornea, which propels the adoption of the dry eye treatment device market.
The US market dominated the North America Dry Eye Treatment Devices Market by Country in 2021; thereby, achieving a market value of $93.2 million by 2028. The Canada market is experiencing a CAGR of 9.1% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 8.1% during (2022 - 2028).
Based on Technology, the market is segmented into Meibomian Gland Expression (MGX), Broadband light (BBL), Intense Pulsed Light (IPL) and Combination (MGX+IPL). Based on End User, the market is segmented into Ophthalmic Clinics, Hospitals and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Dry Eye Treatment Devices Market is Estimated to reach $348.8 Million by 2028, at a CAGR of 7.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiBo Medical Group, Sight Sciences, Inc., Lumenis Ltd., ESW Vision SAS, Johnson & Johnson Vision Care, Inc. and Alcon, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- Meibomian Gland Expression (MGX)
- Broadband light (BBL)
- Intense Pulsed Light (IPL)
- Combination (MGX+IPL)
By End User
- Ophthalmic Clinics
- Hospitals
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- MiBo Medical Group
- Sight Sciences, Inc.
- Lumenis Ltd.
- ESW Vision SAS
- Johnson & Johnson Vision Care, Inc.
- Alcon, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Dry Eye Treatment Devices Market, by Technology
1.4.2 North America Dry Eye Treatment Devices Market, by End User
1.4.3 North America Dry Eye Treatment Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Dry Eye Treatment Devices Market by Technology
3.1 North America Meibomian Gland Expression (MGX) Market by Country
3.2 North America Broadband light (BBL) Market by Country
3.3 North America Intense Pulsed Light (IPL) Market by Country
3.4 North America Combination (MGX+IPL) Market by Country
Chapter 4. North America Dry Eye Treatment Devices Market by End-use
4.1 North America Ophthalmic Clinics Market by Country
4.2 North America Hospitals Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Dry Eye Treatment Devices Market by Country
5.1 US Dry Eye Treatment Devices Market
5.1.1 US Dry Eye Treatment Devices Market by Technology
5.1.2 US Dry Eye Treatment Devices Market by End-use
5.2 Canada Dry Eye Treatment Devices Market
5.2.1 Canada Dry Eye Treatment Devices Market by Technology
5.2.2 Canada Dry Eye Treatment Devices Market by End-use
5.3 Mexico Dry Eye Treatment Devices Market
5.3.1 Mexico Dry Eye Treatment Devices Market by Technology
5.3.2 Mexico Dry Eye Treatment Devices Market by End-use
5.4 Rest of North America Dry Eye Treatment Devices Market
5.4.1 Rest of North America Dry Eye Treatment Devices Market by Technology
5.4.2 Rest of North America Dry Eye Treatment Devices Market by End-use
Chapter 6. Company Profiles
6.1 Lumenis Ltd.
6.1.1 Company Overview
6.1.2 Recent strategies and developments:
6.1.2.1 Approval:
6.2 Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental &Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 SWOT Analysis
6.3 Alcon, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product Launches and Product Expansions:
6.3.5.2 Acquisitions:
6.4 Sight Sciences, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches and Product Expansions:
6.5 MiBo Medical Group
6.5.1 Company Overview
6.6 ESW vision SAS
6.6.1 Company Overview
TABLE 1 North America Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 2 North America Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 3 North America Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 4 North America Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 5 North America Meibomian Gland Expression (MGX) Market by Country, 2018 - 2021, USD Thousands
TABLE 6 North America Meibomian Gland Expression (MGX) Market by Country, 2022 - 2028, USD Thousands
TABLE 7 North America Broadband light (BBL) Market by Country, 2018 - 2021, USD Thousands
TABLE 8 North America Broadband light (BBL) Market by Country, 2022 - 2028, USD Thousands
TABLE 9 North America Intense Pulsed Light (IPL) Market by Country, 2018 - 2021, USD Thousands
TABLE 10 North America Intense Pulsed Light (IPL) Market by Country, 2022 - 2028, USD Thousands
TABLE 11 North America Combination (MGX+IPL) Market by Country, 2018 - 2021, USD Thousands
TABLE 12 North America Combination (MGX+IPL) Market by Country, 2022 - 2028, USD Thousands
TABLE 13 North America Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 14 North America Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 15 North America Ophthalmic Clinics Market by Country, 2018 - 2021, USD Thousands
TABLE 16 North America Ophthalmic Clinics Market by Country, 2022 - 2028, USD Thousands
TABLE 17 North America Hospitals Market by Country, 2018 - 2021, USD Thousands
TABLE 18 North America Hospitals Market by Country, 2022 - 2028, USD Thousands
TABLE 19 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 20 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 21 North America Dry Eye Treatment Devices Market by Country, 2018 - 2021, USD Thousands
TABLE 22 North America Dry Eye Treatment Devices Market by Country, 2022 - 2028, USD Thousands
TABLE 23 US Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 24 US Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 25 US Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 26 US Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 27 US Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 28 US Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 29 Canada Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 30 Canada Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 31 Canada Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 32 Canada Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 33 Canada Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 34 Canada Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 35 Mexico Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 36 Mexico Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 37 Mexico Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 38 Mexico Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 39 Mexico Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 40 Mexico Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 41 Rest of North America Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 42 Rest of North America Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 43 Rest of North America Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 44 Rest of North America Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 45 Rest of North America Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 46 Rest of North America Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 47 key Information – Lumenis Ltd.
TABLE 48 Key information – Johnson & Johnson
TABLE 49 key information – Alcon, Inc.
TABLE 50 Key Information – Sight Sciences, Inc.
TABLE 51 Key Information – MiBo Medical Group
TABLE 52 Key Information – ESW vision SAS
List of Figures
FIG 1 Methodology for the research
FIG 2 SWOT analysis: Johnson & Johnson
FIG 3 Recent strategies and developments: Alcon, Inc.